Cytomegalovirus seroprevalence as a risk factor for poor outcome in acute respiratory distress syndrome

Critical Care Medicine

Volumn 43, Issue 2, 2015, Pages 394-400

  Ong, David S Y ^a   Klouwenberg, Peter M C Klein ^a   Lunel, Frans M Verduyn ^a   Spitoni, Cristian ^a,b   Frencken, Jos F ^a   Dekker, Huberta A T ^a   Schultz, Marcus J ^c   Bonten, Marc J M ^a   Cremer, Olaf L ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Acute respiratory distress syndrome; Cytomegalovirus; Reactivation; Sepsis; Seroprevalence

Indexed keywords

C REACTIVE PROTEIN; CORTICOSTEROID; ANTIVIRUS AGENT;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; APACHE; ARTICLE; ARTIFICIAL VENTILATION; BODY POSTURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CYTOMEGALOVIRUS; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; HUMAN; INFECTION RISK; INTENSIVE CARE UNIT; LUNG COMPLIANCE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SEPTIC SHOCK; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SEROPREVALENCE; SEROTYPE; SURVIVOR; VIRUS LOAD; VIRUS REACTIVATION; CHEMOPROPHYLAXIS; CRITICAL ILLNESS; CYTOMEGALOVIRUS INFECTIONS; HETEROZYGOTE; IMMUNOCOMPROMISED PATIENT; MIDDLE AGED; NETHERLANDS; RESPIRATORY DISTRESS SYNDROME, ADULT;

AGED; ANTIVIRAL AGENTS; CARRIER STATE; CHEMOPREVENTION; CRITICAL ILLNESS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HOSPITAL MORTALITY; HUMANS; IMMUNOCOMPROMISED HOST; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; NETHERLANDS; PROSPECTIVE STUDIES; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, ADULT; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES;

EID: 84925347630     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000000712     Document Type: Article

References (32)

1. Cannon MJ, Schmid DS, Hyde TB: Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol 2010; 20:202-213.
2. Lopo S, Vinagre E, Palminha P, et al: Seroprevalence to cytomegalovirus in the Portuguese population, 2002-2003. Euro Surveill 2011; 16:pii:19896.
3. Staras SA, Dollard SC, Radford KW, et al: Seroprevalence of cytomegalovirus infection in the United States, 1988-1994. Clin Infect Dis 2006; 43:1143-1151.
4. Gandhi MK, Khanna R: Human cytomegalovirus: Clinical aspects, immune regulation, and emerging treatments. Lancet Infect Dis 2004; 4:725-738.
5. Chiche L, Forel JM, Roch A, et al: Active cytomegalovirus infection is common in mechanically ventilated medical intensive care unit patients. Crit Care Med 2009; 37:1850-1857.
6. Heininger A, Haeberle H, Fischer I, et al: Cytomegalovirus reactivation and associated outcome of critically ill patients with severe sepsis. Crit Care 2011; 15:R77.
7. Limaye AP, Kirby KA, Rubenfeld GD, et al: Cytomegalovirus reactivation in critically ill immunocompetent patients. JAMA 2008; 300:413-422.
8. Limaye AP, Boeckh M: CMV in critically ill patients: Pathogen or bystander? Rev Med Virol 2010; 20:372-379.
9. Osawa R, Singh N: Cytomegalovirus infection in critically ill patients: A systematic review. Crit Care 2009; 13:R68.
10. von Müller L, Klemm A, Weiss M, et al: Active cytomegalovirus infection in patients with septic shock. Emerg Infect Dis 2006; 12:1517-1522.
11. Bordes J, Maslin J, Prunet B, et al: Cytomegalovirus infection in severe burn patients monitoring by real-time polymerase chain reaction: A prospective study. Burns 2011; 37:434-439.
12. Chilet M, Aguilar G, Benet I, et al: Virological and immunological features of active cytomegalovirus infection in nonimmunosuppressed patients in a surgical and trauma intensive care unit. J Med Virol 2010; 82:1384-1391.
13. Coisel Y, Bousbia S, Forel JM, et al: Cytomegalovirus and herpes simplex virus effect on the prognosis of mechanically ventilated patients suspected to have ventilator-associated pneumonia. PLoS One 2012; 7:e51340.
14. Cook CH, Yenchar JK, Kraner TO, et al: Occult herpes family viruses may increase mortality in critically ill surgical patients. Am J Surg 1998; 176:357-360.
15. Domart Y, Trouillet JL, Fagon JY, et al: Incidence and morbidity of cytomegaloviral infection in patients with mediastinitis following cardiac surgery. Chest 1990; 97:18-22.
16. Heininger A, Jahn G, Engel C, et al: Human cytomegalovirus infections in nonimmunosuppressed critically ill patients. Crit Care Med 2001; 29:541-547.
17. Jaber S, Chanques G, Borry J, et al: Cytomegalovirus infection in critically ill patients: Associated factors and consequences. Chest 2005; 127:233-241.
18. Ziemann M, Sedemund-Adib B, Reiland P, et al: Increased mortality in long-term intensive care patients with active cytomegalovirus infection. Crit Care Med 2008; 36:3145-3150.
19. Bravo D, Clari MA, Aguilar G, et al: Looking for biological factors to predict the risk of active cytomegalovirus infection in non-immunosuppressed critically ill patients. J Med Virol 2014; 86:827-833.
20. Matthay MA, Zemans RL: The acute respiratory distress syndrome: Pathogenesis and treatment. Annu Rev Pathol 2011; 6:147-163.
21. Cook CH, Martin LC, Yenchar JK, et al: Occult herpes family viral infections are endemic in critically ill surgical patients. Crit Care Med 2003; 31:1923-1929.
22. Bruynseels P, Jorens PG, Demey HE, et al: Herpes simplex virus in the respiratory tract of critical care patients: A prospective study. Lancet 2003; 362:1536-1541.
23. Chiche L, Forel JM, Papazian L: The role of viruses in nosocomial pneumonia. Curr Opin Infect Dis 2011; 24:152-156.
24. Chen K, Kolls JK: T cell-mediated host immune defenses in the lung. Annu Rev Immunol 2013; 31:605-633.
25. Reddehase MJ, Podlech J, Grzimek NK: Mouse models of cytomegalovirus latency: Overview. J Clin Virol 2002; 25(Suppl 2):S23-S36.
26. Papazian L, Doddoli C, Chetaille B, et al: A contributive result of openlung biopsy improves survival in acute respiratory distress syndrome patients. Crit Care Med 2007; 35:755-762.
27. Klein Klouwenberg PM, Ong DS, Bos LD, et al: Interobserver agreement of Centers for Disease Control and Prevention criteria for classifying infections in critically ill patients. Crit Care Med 2013; 41:2373-2378.
28. Bernard GR, Artigas A, Brigham KL, et al: The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149:818-824.
29. Ranieri VM, Rubenfeld GD, Thompson BT, et al: Acute respiratory distress syndrome: The Berlin Definition. JAMA 2012; 307:2526-2533.
30. van Doornum GJ, Guldemeester J, Osterhaus AD, et al: Diagnosing herpesvirus infections by real-time amplification and rapid culture. J Clin Microbiol 2003; 41:576-580.
31. De Vlieger G, Meersseman W, Lagrou K, et al: Cytomegalovirus serostatus and outcome in nonimmunocompromised critically ill patients. Crit Care Med 2012; 40:36-42.
32. Kalil AC, Florescu DF: Prevalence and mortality associated with cytomegalovirus infection in nonimmunosuppressed patients in the intensive care unit. Crit Care Med 2009; 37:2350-2358.